Solid Tumors
📧 Sign up to get email alerts when something new happens for Solid Tumors.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-01-21Clinical Trial Update: A Study of BL-M17D1 in Patients With Locally Advanced or Metastatic HER2 Positive/Negative Breast Cancer and Other Solid Tumors [Phase 1]
A Phase 1 trial evaluating BL-M17D1 in locally advanced or metastatic breast cancer (HER2 positive and negative) and other solid tumors is c…
-
CLINICAL_TRIALS research · 2026-01-20Clinical Trial Update: Siltuximab for the Prevention of Severe Immune-Related Adverse Events During Immune Checkpoint Inhibitor Rechallenge in Patients With Advanced Cancer, CIRES Trial [Phase 2]
This Phase 2 clinical trial evaluates siltuximab to prevent severe immune-related adverse events during rechallenge with immune checkpoint i…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Evaluation of the Effect of Itraconazole on the Pharmacokinetics of HS-20093 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 trial evaluating the effect of itraconazole on the pharmacokinetics of HS-20093 in patients with advanced solid tumors.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Study of RGL-270 Single Drug and Combined With Adebelimab in Patients in Patients at High Risk of Recurrence After Radical Treatment of Malignant Solid Tumors [Phase 1]
This is a Phase 1 clinical trial evaluating RGL-270 alone and in combination with Adebelimab for high-risk recurrence after radical treatmen…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: JAB-23E73 in Adult Participants With Advanced Solid Tumors With KRAS Alteration [Phase 1, Phase 2]
This is a Phase 1/2 clinical trial evaluating JAB-23E73 in adults with KRAS-altered advanced solid tumors; the study is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: A Study to Test a New Immunotherapy, ABX-001, Alone and in Combination With the Marketed Drug, Pembrolizumab, for the Treatment of Tumors Previously Treated With Other Therapies [Phase 1]
A Phase 1 clinical trial update describes ABX-001, an experimental immunotherapy, given alone and in combination with pembrolizumab for adva…
-
CLINICAL_TRIALS research · 2026-01-15Clinical Trial Update: A Study of DM002 in Patients With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial for DM002 in patients with advanced solid tumors is recruiting, including ovarian cancer, prostate cancer, endometria…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Safety and Pharmacokinetics of NM6603 in Chinese Patients With Advanced Solid Tumors [Phase 1]
Phase 1 safety and pharmacokinetics study of NM6603 in Chinese patients with advanced solid tumors is being conducted and is currently recru…
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Phase I/II Clinical Study of WJ22096 Tablets in Patients With Advanced Tumors [Phase 1, Phase 2]
A Phase I/II study of WJ22096 Tablets in patients with advanced solid tumors is currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: A Study of CUSP06 in Patients With Platinum-Refractory/Resistant Ovarian Cancer and Other Advanced Solid Tumors [Phase 1]
A Phase 1 clinical trial evaluating CUSP06 in patients with platinum-refractory/resistant ovarian cancer and other advanced solid tumors is …
-
CLINICAL_TRIALS research · 2026-01-14Clinical Trial Update: Adoption of Audio Recording in the Outpatient Supportive Care Center
This clinical trial update describes the adoption of audio recording in an outpatient supportive care center for patients with solid tumors …
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Phase I Comparative Bioavailability Study [Phase 1]
Clinical trial update describes a Phase I comparative bioavailability study sponsored by AstraZeneca for solid tumors that is currently acti…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Geriatric Evaluation and Management With Survivorship Health Education for Older Survivors of Cancer, GEM-S Trial [Phase 3]
Phase 3 clinical trial evaluating geriatric evaluation and survivorship health education for older cancer survivors (GEM-S) is currently rec…
-
CLINICAL_TRIALS research · 2026-01-13Clinical Trial Update: Evaluation of Early Identification of Cognitive Side Effects of Immunotherapy
This clinical trial update describes a study by the University of Minnesota evaluating methods for early identification of cognitive side ef…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: First-in-Human Study of the GDF-15 Neutralizing Antibody Visugromab (CTL-002) in Patients With Advanced Cancer (GDFATHER) [Phase 1, Phase 2]
First-in-human study of Visugromab (CTL-002), a GDF-15 neutralizing antibody, in adults with advanced solid tumors (Phase 1/2). The trial st…
-
CLINICAL_TRIALS research · 2026-01-12Clinical Trial Update: A Safety, Pharmacokinetic and Clinical Activity Study of NUC-7738 in Patients With Advanced Solid Tumours and Lymphoma [Phase 1, Phase 2]
This update covers the Phase 1/2 study of the investigational agent NUC-7738 in patients with advanced solid tumors and lymphoma, focusing o…
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: A Study of SHR-4610 Injection in Patients With Advanced Solid Tumors [Phase 1, Phase 2]
The document reports a Phase 1/2 clinical trial of SHR-4610 injection in patients with advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-09Clinical Trial Update: Evaluation of the Effect of Cordycepin on CD8+ Lymphocytopenia in Patients With Solid Tumors [Phase 2]
A Phase 2 clinical trial is evaluating cordycepin for treating CD8+ lymphocytopenia in patients with solid tumors and is currently recruitin…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Cetuximab β Combined With PRaG Regimen in the Treatment of EGFR-positive Advanced Refractory Solid Tumors [Phase 2]
A Phase 2 clinical trial is evaluating Cetuximab beta in combination with the PRaG regimen for EGFR-positive advanced refractory solid tumor…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Urolithin A in Patients With Previously Untreated Solid Tumors Receiving Immune Checkpoint Inhibitors [NA]
This entry reports a recruiting clinical trial evaluating urolithin A in patients with previously untreated solid tumors receiving immune ch…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: Impact of Physician Behavior on Cancer Distress
A Mayo Clinic-sponsored trial evaluating whether physician communication and behavior affect cancer-related distress in patients with hemato…
-
CLINICAL_TRIALS research · 2026-01-08Clinical Trial Update: A Clinical Trial of SIBP-A19 Injection in the Treatment of Advanced Malignant Solid Tumor Patients [Phase 1]
Phase 1 clinical trial evaluating SIBP-A19 Injection for advanced solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Phase I /IIa Study of RC88-ADC in Subjects With Advanced Malignant Solid Tumors [Phase 1, Phase 2]
This clinical trial update reports the completion of a Phase I/IIa study of RC88-ADC in subjects with advanced malignant solid tumors.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Clinical Trial of SIBP-A18 Injection in the Treatment of Advanced Malignant Solid Tumor Patients [Phase 1]
Phase 1 clinical trial evaluating SIBP-A18 injection in adults with advanced malignant solid tumors, currently recruiting.
-
CLINICAL_TRIALS research · 2026-01-07Clinical Trial Update: A Study of GSK5764227 in Combination With Standard of Care (SoC) or Other Agents in Participants With Advanced Solid Tumors [Phase 1]
Phase 1 clinical trial evaluating GSK5764227 in combination with standard of care or other agents in participants with advanced solid tumors…